These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 38696456)

  • 41. Seroprevalence of antibodies to SARS-CoV-2 in healthcare workers: a cross-sectional study.
    Ebinger JE; Botwin GJ; Albert CM; Alotaibi M; Arditi M; Berg AH; Binek A; Botting P; Fert-Bober J; Figueiredo JC; Grein JD; Hasan W; Henglin M; Hussain SK; Jain M; Joung S; Karin M; Kim EH; Li D; Liu Y; Luong E; McGovern DPB; Merchant A; Merin N; Miles PB; Minissian M; Nguyen TT; Raedschelders K; Rashid MA; Riera CE; Riggs RV; Sharma S; Sternbach S; Sun N; Tourtellotte WG; Van Eyk JE; Sobhani K; Braun JG; Cheng S
    BMJ Open; 2021 Feb; 11(2):e043584. PubMed ID: 33579769
    [TBL] [Abstract][Full Text] [Related]  

  • 42. SARS-CoV-2 Infection and Antibody Response in a Symptomatic Cat from Italy with Intestinal B-Cell Lymphoma.
    Klaus J; Palizzotto C; Zini E; Meli ML; Leo C; Egberink H; Zhao S; Hofmann-Lehmann R
    Viruses; 2021 Mar; 13(3):. PubMed ID: 33806922
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Seroprevalence of SARS-CoV-2 in Guilan Province, Iran, April 2020.
    Shakiba M; Nazemipour M; Salari A; Mehrabian F; Nazari SSH; Rezvani SM; Ghasempour Z; Heidarzadeh A; Mansournia MA
    Emerg Infect Dis; 2021 Feb; 27(2):636-638. PubMed ID: 33349310
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Seroprevalence of SARS-CoV-2 antibodies among rural healthcare workers.
    Neises JZ; Hossain MS; Sultana R; Wanniarachchi KN; Wollman JW; Nelson E; Specker BL; Hoppe AD; Lawson SR; Thiex NW
    J Med Virol; 2021 Dec; 93(12):6611-6618. PubMed ID: 34289148
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Serological evidence of SARS-CoV-2 and co-infections in stray cats in Spain.
    Villanueva-Saz S; Giner J; Tobajas AP; Pérez MD; González-Ramírez AM; Macías-León J; González A; Verde M; Yzuel A; Hurtado-Guerrero R; Pardo J; Santiago L; Paño-Pardo JR; Ruíz H; Lacasta DM; Sánchez L; Marteles D; Gracia AP; Fernández A
    Transbound Emerg Dis; 2022 May; 69(3):1056-1064. PubMed ID: 33686768
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Seroprevalence of SARS-CoV-2 Antibodies Among Children in School and Day Care in Montreal, Canada.
    Zinszer K; McKinnon B; Bourque N; Pierce L; Saucier A; Otis A; Cheriet I; Papenburg J; Hamelin MÈ; Charland K; Carbonneau J; Zahreddine M; Savard A; Fortin G; Apostolatos A; Haley N; Ratté N; Laurin I; Nguyen CT; Conrod P; Boivin G; De Serres G; Quach C
    JAMA Netw Open; 2021 Nov; 4(11):e2135975. PubMed ID: 34812845
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prevalence of antibodies to SARS-CoV-2 in Irish hospital healthcare workers.
    Allen N; Riain UN; Conlon N; Ferenczi A; Carrion Martin AI; Domegan L; Walsh C; Doherty L; O'Farrelly C; Higgins E; Kerr C; McGrath J; ; Fleming C; Bergin C
    Epidemiol Infect; 2021 Apr; 149():e157. PubMed ID: 33902786
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Estimates and Determinants of SARS-Cov-2 Seroprevalence and Infection Fatality Ratio Using Latent Class Analysis: The Population-Based Tirschenreuth Study in the Hardest-Hit German County in Spring 2020.
    Wagner R; Peterhoff D; Beileke S; Günther F; Berr M; Einhauser S; Schütz A; Niller HH; Steininger P; Knöll A; Tenbusch M; Maier C; Korn K; Stark KJ; Gessner A; Burkhardt R; Kabesch M; Schedl H; Küchenhoff H; Pfahlberg AB; Heid IM; Gefeller O; Überla K
    Viruses; 2021 Jun; 13(6):. PubMed ID: 34200766
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Low Prevalence of SARS-CoV-2 Antibodies in Canine and Feline Serum Samples Collected during the COVID-19 Pandemic in Hong Kong and Korea.
    Go YY; Carrai M; Choi YR; Brackman CJ; Tam KWS; Law PYT; Woodhouse F; Gray J; Kim JH; Park J; Jeon CW; Jang H; Magouras I; Decaro N; Cheng SMS; Peiris M; Beatty JA; Barrs VR
    Viruses; 2023 Feb; 15(2):. PubMed ID: 36851796
    [TBL] [Abstract][Full Text] [Related]  

  • 50. SARS-CoV-2 seroprevalence among blood donors after the first COVID-19 wave in Canada.
    Saeed S; Drews SJ; Pambrun C; Yi QL; Osmond L; O'Brien SF
    Transfusion; 2021 Mar; 61(3):862-872. PubMed ID: 33527398
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prevalence of anti-severe acute respiratory syndrome coronavirus 2 antibodies in cats in Germany and other European countries in the early phase of the coronavirus disease-19 pandemic.
    Adler JM; Weber C; Wernike K; Michelitsch A; Friedrich K; Trimpert J; Beer M; Kohn B; Osterrieder K; Müller E
    Zoonoses Public Health; 2022 Aug; 69(5):439-450. PubMed ID: 35238485
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Sentinel seroprevalence of SARS-CoV-2 in Gauteng Province, South Africa, August - October 2020.
    George JA; Khoza S; Mayne E; Dlamini S; Kone N; Jassat W; Chetty K; Centner CM; Pillay T; Maphayi M; Mabuza D; Maposa I; Cassim N
    S Afr Med J; 2021 Nov; 111(11):1078-1083. PubMed ID: 34949273
    [TBL] [Abstract][Full Text] [Related]  

  • 53. SARS-CoV-2 transmission among children and staff in daycare centres during a nationwide lockdown in France: a cross-sectional, multicentre, seroprevalence study.
    Lachassinne E; de Pontual L; Caseris M; Lorrot M; Guilluy C; Naud A; Dommergues MA; Pinquier D; Wannepain E; Hausherr E; Jung C; Gajdos V; Cohen R; Zahar JR; Brichler S; Basmaci R; Boelle PY; Bloch-Queyrat C; Aupiais C;
    Lancet Child Adolesc Health; 2021 Apr; 5(4):256-264. PubMed ID: 33571450
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Seroprevalence of SARS-CoV-2, Symptom Profiles and Sero-Neutralization in a Suburban Area, France.
    Gégout Petit A; Jeulin H; Legrand K; Jay N; Bochnakian A; Vallois P; Schvoerer E; Guillemin F
    Viruses; 2021 Jun; 13(6):. PubMed ID: 34200070
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Enhanced surveillance of COVID-19 in Scotland: population-based seroprevalence surveillance for SARS-CoV-2 during the first wave of the epidemic.
    Dickson E; Palmateer NE; Murray J; Robertson C; Waugh C; Wallace LA; Mathie L; Heatlie K; Mavin S; Gousias P; Von Wissman B; Goldberg DJ; McAuley A
    Public Health; 2021 Jan; 190():132-134. PubMed ID: 33453689
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Seroprevalence of SARS-CoV-2 Antibodies in Children and Adults in St. Louis, Missouri, USA.
    Smith BK; Janowski AB; Danis JE; Harvey IB; Zhao H; Dai YN; Farnsworth CW; Gronowski AM; Roper S; Fremont DH; Wang D
    mSphere; 2021 Feb; 6(1):. PubMed ID: 33536325
    [TBL] [Abstract][Full Text] [Related]  

  • 57. SARS-CoV-2 seroprevalence and asymptomatic viral carriage in healthcare workers: a cross-sectional study.
    Shields A; Faustini SE; Perez-Toledo M; Jossi S; Aldera E; Allen JD; Al-Taei S; Backhouse C; Bosworth A; Dunbar LA; Ebanks D; Emmanuel B; Garvey M; Gray J; Kidd IM; McGinnell G; McLoughlin DE; Morley G; O'Neill J; Papakonstantinou D; Pickles O; Poxon C; Richter M; Walker EM; Wanigasooriya K; Watanabe Y; Whalley C; Zielinska AE; Crispin M; Wraith DC; Beggs AD; Cunningham AF; Drayson MT; Richter AG
    Thorax; 2020 Dec; 75(12):1089-1094. PubMed ID: 32917840
    [TBL] [Abstract][Full Text] [Related]  

  • 58. SARS-CoV-2 lateral flow assays for possible use in national covid-19 seroprevalence surveys (React 2): diagnostic accuracy study.
    Moshe M; Daunt A; Flower B; Simmons B; Brown JC; Frise R; Penn R; Kugathasan R; Petersen C; Stockmann H; Ashby D; Riley S; Atchison C; Taylor GP; Satkunarajah S; Naar L; Klaber R; Badhan A; Rosadas C; Marchesin F; Fernandez N; Sureda-Vives M; Cheeseman H; O'Hara J; Shattock R; Fontana G; Pallett SJC; Rayment M; Jones R; Moore LSP; Ashrafian H; Cherapanov P; Tedder R; McClure M; Ward H; Darzi A; Elliott P; Cooke GS; Barclay WS;
    BMJ; 2021 Mar; 372():n423. PubMed ID: 33653694
    [TBL] [Abstract][Full Text] [Related]  

  • 59. SARS-CoV-2 Infections and Viral Isolations among Serially Tested Cats and Dogs in Households with Infected Owners in Texas, USA.
    Hamer SA; Pauvolid-Corrêa A; Zecca IB; Davila E; Auckland LD; Roundy CM; Tang W; Torchetti MK; Killian ML; Jenkins-Moore M; Mozingo K; Akpalu Y; Ghai RR; Spengler JR; Barton Behravesh C; Fischer RSB; Hamer GL
    Viruses; 2021 May; 13(5):. PubMed ID: 34069453
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A study of the evolution of the third COVID-19 pandemic wave in the Athens metropolitan area, Greece, through two cross-sectional seroepidemiological surveys: March, June 2021.
    Maltezou HC; Krumbholz B; Mavrouli M; Tseroni M; Gamaletsou MN; Botsa E; Anastassopoulou C; Gikas A; Fournarakou E; Kavieri M; Koureli A; Mandilara D; Marinopoulou A; Theodorikakou A; Tsiahris P; Zarzali A; Pournaras S; Lourida A; Elefsiniotis I; Vrioni G; Sipsas NV; Tsakris A
    J Med Virol; 2022 Apr; 94(4):1465-1472. PubMed ID: 34812522
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.